title: G-CSF administration following peripheral blood selected CD34-positive cells autologous transplantation accelerates haematological recovery after myeloablative therapy.
authors.forename: H T
authors.initials: HT
authors.lastname: Hassan
authors.forename: M
authors.initials: M
authors.lastname: Stockschläder
authors.forename: W
authors.initials: W
authors.lastname: Krüger
authors.forename: H
authors.initials: H
authors.lastname: Hoffknecht
authors.forename: A R
authors.initials: AR
authors.lastname: Zander
mesh_terms: D000328:Adult; D018952:Antigens, CD34; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006412:Hematopoietic Stem Cells; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous
chemical_list: D018952:Antigens, CD34; D016179:Granulocyte Colony-Stimulating Factor